Open Access
Concurrent cisplatin and radiotherapy in advanced head and neck cancer
Author(s) -
Rehan Asif,
Kamlesh Chandra,
Vanita Chopra,
Madan Lal Brahma Bhatt
Publication year - 2003
Publication title -
indian journal of otolaryngology and head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 2231-3796
pISSN - 0973-7707
DOI - 10.1007/bf02974612
Subject(s) - medicine , radiation therapy , otorhinolaryngology , cisplatin , head and neck cancer , head and neck , chemotherapy , head and neck surgery , oncology , adjuvant , surgery
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m(2) intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.